Your browser doesn't support javascript.
loading
HPV vaccination: the beginning of the end of cervical cancer? - A Review.
Lepique, Ana Paula; Rabachini, Tatiana; Villa, Luisa Lina.
Afiliação
  • Lepique AP; Instituto Ludwig de Pesquisa sobre o Câncer, São Paulo, SP, Brasil, 01323-903. alepique@ludwig.org.br
Mem Inst Oswaldo Cruz ; 104(1): 1-10, 2009 Feb.
Article em En | MEDLINE | ID: mdl-19274369
ABSTRACT
Human papillomavirus (HPV) is responsible for all cases of cervical cancer, as well as a great percentage of other anogenital tumors and oropharyngeal tumors. Since the main etiologic factor for these diseases is a virus, prophylactic measures are the best way to reduce the burden caused by the infection and associated disease. This review brings up to date information on the two commercially available prophylactic HPV vaccines against HPV, as well as presenting the ongoing research on HPV peptide, protein and dendritic cell based therapeutic vaccines.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Neoplasias do Colo do Útero / Infecções por Papillomavirus / Vacinas contra Papillomavirus Limite: Animals / Female / Humans Idioma: En Revista: Mem Inst Oswaldo Cruz Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Neoplasias do Colo do Útero / Infecções por Papillomavirus / Vacinas contra Papillomavirus Limite: Animals / Female / Humans Idioma: En Revista: Mem Inst Oswaldo Cruz Ano de publicação: 2009 Tipo de documento: Article